Neogen (NEOG) EPS (Diluted) (QoQ) (2010 - 2026)
Neogen (NEOG) EPS (Diluted) (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.61 Bn | 175.32 Bn | 6.27 Bn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn |
| 3 | Medtronic | 108.22 Bn | 99.00 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.29 Bn | 66.84 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.30 Bn | 44.63 Bn | 1.29 Bn |
| 6 | Dexcom | 28.31 Bn | 27.19 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.03 Bn | 25.75 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - |
| 9 | Koninklijke Philips | 24.04 Bn | 20.91 Bn | 2.07 Bn |
| 10 | Neogen | 2.05 Bn | 1.89 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -6.61% |
| Nov 30, 2025 | -143.81% |
| Aug 31, 2025 | 105.57% |
| May 31, 2025 | -5,880.28% |
| Feb 28, 2025 | 97.61% |
| Nov 30, 2024 | -3,516.72% |
| Aug 31, 2024 | -132.62% |
| May 31, 2024 | -167.95% |
| Feb 29, 2024 | 42.06% |
| Nov 30, 2023 | -332.47% |
| Aug 31, 2023 | -79.49% |
| May 31, 2023 | -10.72% |
| Feb 28, 2023 | 119.55% |
| Nov 30, 2022 | -500.84% |
| Aug 31, 2022 | -63.30% |
| May 31, 2022 | 161.45% |
| Feb 28, 2022 | -49.74% |
| Nov 30, 2021 | -36.60% |
| Aug 31, 2021 | 18.00% |
| May 31, 2021 | 7.47% |